Revenue segments as reported by the company.

Beauty

Grooming

Health Care

Fabric & Home Care

Baby, Feminine & Family Care

Corporate

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Goodwill and indefinite-lived intangibles impairment charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Procter & Gamble

Old Spice is a brand of male grooming products encompassing deodorants and antiperspirants, shampoos, body washes, and soaps.

Old Spice

Crest is a brand of toothpaste and other oral hygiene products sold worldwide.

Crest

Tampax is a brand of tampon sold in over 100 countries.

Tampax

Tide

Braun AG, is a German consumer products company based in Kronberg. From 1984 until 2007, Braun was a wholly owned subsidiary of The Gillette Company, which had purchased a controlling interest in the company in 1967. Braun is now a wholly owned subsidiary of Procter & Gamble, which acquired Gillette in 2005. On 16 April 2012, De'Longhi bought perpetual rights to manufacture Braun branded products from Procter & Gamble in the small appliance segment. Procter & Gamble will continue to own the Braun brand.

Braun

Gillette is a brand of men's and women's safety razors and other personal care products including shaving supplies.

Gillette

Olay is a brand of beauty products focusing on skin care.

Olay

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Procter & Gamble reports strong Q3 performance and navigates challenges

Procter & Gamble delivered strong Q3 results, raising its guidance for organic sales growth and maintaining its outlook for core earnings per share growth. The company faces challenges related to sustained cost pressures, supply constraints, and volume recovery in certain regions. However, opportunities exist in travel retail reopening, innovation strategies, and continued resilience.

Procter & Gamble reports Q2 growth amid global challenges

Procter & Gamble's Q2 showed mixed results with strong U.S. sales but challenges in Greater China.
Guidance raised for organic sales growth, but significant headwinds persist from raw material costs and currency fluctuations.
Investments in brand superiority and supply chain optimization present growth opportunities.
Balancing input cost inflation and navigating market uncertainties remain key challenges.

Procter & Gamble reports robust Q3 results amidst global challenges

Procter & Gamble's Q3 performance reflects strong execution of strategies, leading to organic sales growth and margin improvement.
Despite challenges from costs and supply constraints, P&G's focus on innovation and market leadership positions it well for future growth.
Opportunities in China, Latin America, and Europe, along with continued productivity improvements, offer avenues for sustained growth and market expansion.
P&G's long-term approach to navigating challenges and serving stakeholders effectively underscores its resilience and commitment to sustainable growth.

Procter & Gamble posts robust Q4 earnings amidst market challenges

Procter & Gamble (PG) reported strong financial performance in Q4 2023 and fiscal year 2023, driven by organic sales growth and operational efficiency.
The company's strategic focus on innovation, market share growth, and cost management positions it well to navigate challenges and capitalize on opportunities.
Despite challenges in the China market and supply chain disruptions, P&G remains committed to driving growth, enhancing productivity, and delivering shareholder value.

Procter & Gamble reports strong Q1 results and outlines growth strategies

Procter & Gamble's Q1 performance reflects robust sales growth and financial strength.
While facing challenges in certain regions, the company remains focused on driving innovation and value creation.
Opportunities in commodity tailwinds and marketing investments position PG for continued growth.
Confidence in strategy and commitment to balanced growth underscore PG's resilience.

Procter & Gamble reports robust Q2 earnings amidst market challenges

Procter & Gamble's Q2 2024 earnings call showcased strong performance, emphasizing sales growth, margin improvement, and strategic focus on innovation. While facing challenges in key markets, P&G remains resilient and focused on overcoming obstacles to drive growth. The company's opportunities lie in maintaining sales growth, enhancing earnings, and strategic market decisions.

Procter & Gamble (PG) posts robust Q3 results, eyes innovation for growth

Procter & Gamble (PG) reported strong Q3 performance, highlighting growth in key markets and increased earnings. Despite challenges in China and the Middle East, the company remains focused on innovation and market growth to drive future success.

Procter & Gamble reports strong Q4 results, eyes innovation for growth

Procter & Gamble's Q4 performance showcases resilience and strategic focus amidst regional challenges. The company's emphasis on innovation, market growth, and consumer delight positions it well for sustained positive results and value creation.

Procter & Gamble reports 2% organic sales growth in Q1 2025

Procter & Gamble delivered steady organic sales growth, strong core earnings, and maintained guidance for fiscal year '25. Challenges in Greater China and Europe require attention, while opportunities in Latin America and shareholder value creation through dividends and stock repurchases are key focus areas.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Akamai Technologies

Arrow Electronics

Herbalife

Dow continued its surge after Pfizer﻿﻿ and BioNTech revealed yesterday that studies show that their COVID-19 vaccine is more than 90% effective. For investors looking to make the most of this rally, our deep learning algorithms have crunched the data to give you a set of Top Buys.

Top Stocks To Buy Today As Investors Shift From Stay-At-Home Stocks

Dow Inc

Microsoft

NIKE

A COVID-19 vaccine likely to benefit the Dow the most as it is more inclined toward cyclical stocks. Five among these are NIKE (NKE), Dow (DOW), The Procter & Gamble (PG), 3M (MMM) and Microsoft (MSFT).

5 Blue-Chip Stocks to Buy on Coronavirus Vaccine Hope

Johnson & Johnson

Pinterest

Teladoc

If you're looking for stalwart performers that could carry your portfolio through another market crash, consider these companies.

5 Hot Stocks to Buy in November

DocuSign

Novartis

Block

Twilio

Visa

Zoom Video

Do you want to know how to invest in startups? Start by taking at look at these seven unicorn startups and their unique business models.

7 Unicorn Startups to Watch Into 2021

Apple

Amazon

Alibaba

Salesforce

One thing is clear in today's markets, big caps are the smart play, whether as safe harbor in a storm or growth plays on bull markets. The post 7 Hot Stocks To Buy With Mega-Cap Status appeared first on InvestorPlace.

7 Hot Stocks To Buy With Mega-Cap Status

Cisco Systems

Chevron

DouYu International Holdings Ltd

Honeywell

Intel

UnitedHealth Group

Verizon

Walmart

Two new sample breakout stocks for Week 45 with better than 10% short-term upside potential. Now up an average +244.3% YTD. This past week no stocks gained over 10% and the Momentum Gauge® turned negative Monday in a strong warning signal of market declines. CCRN gained +10.1% on Friday.

Week 45 MDA Breakout Forecast - November: Short-Term Picks To Give You An Edge

CINCINNATI, Oct. 30, 2020 /PRNewswire/ -- Following the success of its first-ever Virtual Innovation Challenge in June, P&G Ventures, the early-stage startup studio within P&G (NYSE:PG), is now accepting submissions for its next virtual pitch competition. Entrepreneurs, inventors, and...

Procter & Gamble Ventures Brings Innovation Challenge Online for CES 2021

Procter & Gamble (NYSE:PG) has most recently been in the news for its tender offer to buy back the company's bonds from the market. This offer follows what could be termed as a stellar quarterly result, where the company managed to beat Wall Street's expectations.

Procter & Gamble Is on a Roll

PepsiCo

The consumer-packaged goods business has seen the future and it is direct-to-consumer (D2C). Recent earnings calls and other developments show that while CPG companies averaged about a 5 to 10 percent sales increase during Q3, they're also looking at the D2C space for future growth.

P&G, Pepsi And Other CPG Brands Continue Push Toward Direct-To-Consumer Sales

The acceleration in this consumer goods giant's business could last longer than you think.

Procter & Gamble: Strong Performance May Outlast COVID-19

Abbott Labs

Anheuser-Busch InBev

H&R Block

Kroger

NextEra Energy

Novavax

Sturm, Ruger & Company

Vista Outdoor

No matter who wins the presidential election, the results will be jarring to millions of Americans. Prepare yourself early by getting into these companies to invest in before 2021.

9 Companies to Invest In Before We Hit 2021

Procter & Gamble (NYSE: PG) price has advanced from $111 above $145 in less than six months and the current price stands around $137. Procter & Gamble has found strong support above $130 but the price is still not able to surpass $150 resistance.

Up or down? Procter & Gamble price prediction for November

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE: PG) announced today the pricing of its previously announced debt tender offer to purchase the P&G debt securities listed in the table below (collectively, the “Securities”). The tender offer is being made solely pursuant to P&G's Offer to Purchase, dated October 13, 2020, and the related Letter of Transmittal, as previously amended. As of the Early Tender Deadline of 5:00 p.m., New York City time, on October 26, 2020,

Procter & Gamble Announces Pricing of Its Debt Tender Offer

PG stock is a rock-solid choice to anchor a portfolio. It offers consistent returns and it is poised for continued solid growth in 2021.

Procter & Gamble Stock Offers Consistent Returns in 2021

General Mills

Keurig Dr Pepper Inc

Lululemon Athletica

McCormick

Monster Beverage

Consumer Staples Select Sector SPDR Fund

Consumer Discretionary Select Sector SPDR Fund

Whether you want your consumer stocks to focus on discretionary items or staples, here are 10 of the best buys you can make right now. The post 10 Consumer Stocks for a Reliable Portfolio appeared first on InvestorPlace.

10 Consumer Stocks for a Reliable Portfolio

AstraZeneca

JPMorgan Chase & Co

Starbucks

As market valuations look stretched, its a good time to consider exposure to some low beta safe stocks that feature dependable dividends. The post 4 Safe Stocks to Lock Down Profits appeared first on InvestorPlace.

4 Safe Stocks to Lock Down Profits

This oversized, old-school name has figured out a few new tricks to remain relevant in this digital era.

2 Reasons Procter & Gamble Crushed It This Quarter

Sales gains accelerated to kick off P&G's fiscal 2021.

Procter & Gamble Breaks Down an Unusually Good Quarter

News for Procter & Gamble Stock (PG)